Strides Pharma Science LtdPharmaceuticalsINE939A01011Consolidated₹1219.80+19.60 (+1.63%)Jun-26
Valuation
Market Cap₹11.24K Cr
TTM PE18.33x
Forward PE17.35x
PEG1.78
Book Value₹337.15
P/B3.62x
TTM EPS₹66.56
Fwd EPS₹70.29
TTM Revenue₹5.00K Cr
TTM PAT₹634.41 Cr
TTM EBITDA₹937.01 Cr
TTM EBIT₹727.10 Cr
Last Qtr PAT₹165.49 Cr
Last Qtr EBITDA₹229.78 Cr
Last Qtr EBIT₹173.38 Cr
Profitability
ROE20.42%
ROCE18.87%
TTM NPM12.68%
TTM EBITDA %18.72%
Curr OPM13.03%
Last OPM9.71%
Curr NPM—
Last NPM—
Curr EPS₹17.02
Last EPS₹13.77
Balance sheet
Equity₹92.17 Cr
Reserve₹3.02K Cr
Total Debt₹1,761.69 Cr
D/E0.57x
Interest %24.51%
Curr Interest₹40.56 Cr
Price / range
Close₹1219.80
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+1.63%
1W+3.08%
1M+28.52%
3M+9.81%
6M+34.77%
1Y+39.22%
2Y-10.73%
3Y+151.17%
5Y+100.16%
Diwali+33.52%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits